Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Equativ Brings ChatGPT Ads to Brands as Advertising Partner
-
IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review
-
Kunfupay sees 46% revenue uplift in Peru after integrating one-click checkout enabled by EBANX
-
Form 8.3 - NextEnergy Solar Fund Limited
-
Form 8.3 - Eleco Plc
-
Delinea Named a Winner of the United States Top Workplaces 2026 Award
-
CIRA’s award-winning ‘What’s up with the internet?’ podcast returns for its fourth season to explore Canada’s creator economy
-
Travel Trackers Acquired by Volaris Group
-
Adventist Health Bakersfield Introduces Kern County’s First Next Generation Robotic-Assisted Bronchoscopy
-
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
-
Comscore's Latest AI Intelligence Report Shows Competition Intensifying as Claude and Gemini Gain Ground on ChatGPT
-
Northern Discovery Metals Reports Progress on Stage 1 Exploration at the Vent Project
-
American EcoFuels Inc. (OTC: AEFI) Appoints Veteran Engineering Executive Jeff Saxinger as Chief Technology Officer
-
XFLH Capital Corporation Announces the Signing of a Letter of Intent with Renogen Biolab Inc.
-
Orion Group Holdings Announces Conference Participation
-
ABM Launches Technical Training Center to Help Meet Growing Demand for Semiconductor Talent
-
Bringing Asia-Pacific Innovation to New York for Climate Week NYC and U.S. Investor Roadshow
-
newcleo Begins Trading on Nasdaq Under Symbol "NWCL"
-
Levi Strauss & Co. and Marks & Spencer launch the Fashion Renewable Collaborative to turn climate commitments into renewable electricity action
-
Encore Appoints Former Royal Canadian Air Force Commander Michael Hood as Strategic Advisor
-
Hopsworks unveils the line-up for the 6th Annual Feature Store Summit: 15+ leading companies presenting how they manage their data for AI and agents
-
Reviva to Participate in the Lytham Partners Fall 2026 Investor Conference
-
Meristead Wealth Launches as a National RIA Managing Close to $1.4B in Assets
-
French Army Technical Section (STAT) Awards Novacium a Contract to Supply High-Capacity Prototype Batteries for Tactical Radios
-
RoyaLand (RLNDF) Announces Savoia Calcio's Pursuit of Stadio Giraud Concession, Targeting a Long-Term Strategic Asset
-
Envisagenics and Boehringer Ingelheim Enter Multi-Target Collaboration to Develop First-in-Class Precision Therapies Based on RNA Splicing-Derived Targets for Hard-to-Treat Cancers
-
Clene to Present at Upcoming Investor Conferences
-
NioBay Appoints a New Member to Its Board of Directors
-
PureSky Energy Launches First Community Solar Farm in Illinois, Expanding Access to Clean Energy Benefits for Income-Eligible Households
-
Enlivex Announces Termination of Previously-Announced Financing Payable in RAIN Tokens
-
Swvl Establishes Presence in Madinah, Launching 24/7 Shuttle Service Across Seven Hotels in the Pilgrimage Transport Segment
-
NYSE:MMA - MMA.INC Opens Pre-Sale for Largest TrainAlta UFC GYM Program Cycle Across 27 Locations
-
FactSet Marks a New Era in Enterprise Real-Time Market Data as It Acquires BCC Group International
-
Algorhythm’s CEO Andrew Thompson Issues Shareholder Update Outlining Strategic Vision
-
EagleNXT Provides Update on American-Made Drone and Sensor Shipments from U.S. Headquarters in Allen, Texas
-
Genius Group to host Genius Future Summit on November 5-6, 2026.
-
Host Digital Debuts on NYSE American as HOST and Exercises its Right to Acquire a Second Site from its Sponsor for its AI Data Center Platform
-
Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for
-
Kids Are Back in School. Their Shopping Isn’t Done Yet.
-
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
-
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
-
SailPoint to Host Analyst and Investor Webcast to Recap Navigate Innovations
-
Kognitos Partners with TypeSafe AI to Bring AI Decision Intelligence to Business Users Through English as Code
-
U.S. Ice Cream Makers Join Rollins, Kennedy to Highlight Industry-Wide Action on Artificial Colors
-
Sentient Media Mapped Every Factory Farm in Iowa and We’re Releasing the Data for Free
-
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
-
TTEC Launches New Automotive Customer Experience Program in Cairo
-
Fine Entertainment Launches El Corazón Investment Offering for Accredited Investors
-
Comscore's Latest AI Intelligence Report Shows Competition Intensifying as Claude and Gemini Gain Ground on ChatGPT
-
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncolog
